AngioDynamics, Inc. (ANGO)
15.61
-0.25
(-1.58%)
USD |
NASDAQ |
Sep 02, 16:00
15.61
0.00 (0.00%)
After-Hours: 18:50
AngioDynamics Research and Development Expense (TTM) : 29.45M for May 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | 29.45M |
| February 28, 2026 | 27.86M |
| November 30, 2025 | 27.69M |
| August 31, 2025 | 26.35M |
| May 31, 2025 | 26.22M |
| February 28, 2025 | 26.36M |
| November 30, 2024 | 27.63M |
| August 31, 2024 | 29.86M |
| May 31, 2024 | 31.51M |
| February 29, 2024 | 32.65M |
| November 30, 2023 | 31.31M |
| August 31, 2023 | 29.49M |
| May 31, 2023 | 29.88M |
| February 28, 2023 | 29.89M |
| November 30, 2022 | 30.32M |
| August 31, 2022 | 31.68M |
| May 31, 2022 | 30.74M |
| February 28, 2022 | 31.98M |
| November 30, 2021 | 33.26M |
| August 31, 2021 | 34.78M |
| May 31, 2021 | 36.39M |
| February 28, 2021 | 34.52M |
| November 30, 2020 | 34.35M |
| August 31, 2020 | 32.40M |
| May 31, 2020 | 29.68M |
| Date | Value |
|---|---|
| February 29, 2020 | 29.34M |
| November 30, 2019 | 27.86M |
| August 31, 2019 | 27.18M |
| May 31, 2019 | 28.26M |
| February 28, 2019 | 27.53M |
| November 30, 2018 | 27.08M |
| August 31, 2018 | 26.11M |
| May 31, 2018 | 25.17M |
| February 28, 2018 | 25.70M |
| November 30, 2017 | 25.20M |
| August 31, 2017 | 25.00M |
| May 31, 2017 | 25.27M |
| February 28, 2017 | 25.51M |
| November 30, 2016 | 25.37M |
| August 31, 2016 | 25.63M |
| May 31, 2016 | 25.13M |
| February 29, 2016 | 25.48M |
| November 30, 2015 | 26.52M |
| August 31, 2015 | 26.42M |
| May 31, 2015 | 26.93M |
| February 28, 2015 | 26.40M |
| November 30, 2014 | 26.58M |
| August 31, 2014 | 27.52M |
| May 31, 2014 | 27.51M |
| February 28, 2014 | 27.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 2.153B |
| Penumbra, Inc. | 75.84M |
| Abbott Laboratories | 3.128B |
| Alphatec Holdings, Inc. | 76.69M |
| AtriCure, Inc. | 94.05M |